Factors associated with community use of adjuvant chemotherapy for stage III colon cancer - results from a national cohort study

被引：0
|
作者：
Jackson, C. [1 ]
Hinder, V. [2 ]
Sharples, K. [1 ,2 ]
Jeffery, M. [3 ]
Murray, M. [2 ]
Findlay, M. [2 ]
机构：
[1] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand
[2] Univ Auckland, Canc Trials New Zealand, Auckland 1, New Zealand
[3] Canterbury Reg Canc & Haematol Serv, Canterbury Dist Hlth Board, Christchurch, New Zealand
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31046-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2124
引用
收藏
页码：S372 / S373
页数：2
相关论文
共 50 条
  • [21] Effect of Postoperative Complications on Adjuvant Chemotherapy Use for Stage III Colon Cancer
    Merkow, Ryan P.
    Bentrem, David J.
    Mulcahy, Mary F.
    Chung, Jeanette W.
    Abbott, Daniel E.
    Kmiecik, Thomas E.
    Stewart, Andrew K.
    Winchester, David P.
    Ko, Clifford Y.
    Bilimoria, Karl Y.
    ANNALS OF SURGERY, 2013, 258 (06) : 847 - 853
  • [22] Age and adjuvant chemotherapy use after surgery for stage III colon cancer
    Schrag, D
    Cramer, LD
    Bach, PB
    Begg, CB
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (11) : 850 - 857
  • [23] Effect of postoperative complications on adjuvant chemotherapy use in stage III colon cancer
    Merkow, Ryan P.
    Bentrem, David J.
    Mulcahy, Mary Frances
    Ko, Clifford Y.
    Bilimoria, Karl Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England
    Boyle, J. M.
    Kuryba, A.
    Cowling, T. E.
    Aggarwal, A.
    Hill, J.
    van der Meulen, J.
    Walker, K.
    Braun, M. S.
    CLINICAL ONCOLOGY, 2020, 32 (05) : E135 - E144
  • [25] Chemotherapy use in stage III colon cancer: a National Cancer Database analysis
    Upadhyay, Smrity
    Dahal, Sumit
    Bhatt, Vijaya Raj
    Khanal, Nabin
    Silberstein, Peter T.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2015, 7 (05) : 244 - 251
  • [26] A national evaluation of the use and survival impact of adjuvant chemotherapy in Stage II colon cancer from the national cancer database
    de Paula, Thais Reif
    Gorroochurn, Prakash
    Simon, Hillary L.
    Haas, Eric M.
    Keller, Deborah S.
    COLORECTAL DISEASE, 2022, 24 (01) : 40 - 49
  • [27] Extent of Adjuvant Chemotherapy Use in Stage II and Stage III Colon Cancer through Examination of a National Cancer Data Base (NCDB)
    Nagatomo, K.
    Lefkowitz, A.
    Carp, N.
    Siripurapu, V.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S86 - S86
  • [28] Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study
    Cress, Rosemary D.
    Sabatino, Susan A.
    Wu, Xiao-Cheng
    Schymura, Maria J.
    Rycroft, Randi
    Stuckart, Erik
    Fulton, John
    Shen, Tiefu
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2009, 3 : 107 - 119
  • [29] FACTORS ASSOCIATED WITH RECEIPT OF ADJUVANT CHEMOTHERAPY IN STAGE II COLON CANCER.
    Ginesi, M.
    Bliggenstorfer, J.
    Mugayo, D.
    Xu, S.
    Jodeh, D.
    Selfridge, J. E.
    Stein, S. L.
    Steinhagen, E.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 35 - 36
  • [30] Lymph node yield and tumour subsite are associated with survival in stage I–III colon cancer: results from a national cohort study
    Jakob Lykke
    Jacob Rosenberg
    Per Jess
    Ole Roikjaer
    World Journal of Surgical Oncology, 17
12345